Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma
Clinical trial NCT03528408 · UNKNOWN
Trial details
- NCT number
- NCT03528408
- Sponsor
- Suthee Rapisuwon
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-26
- Primary completion
- 2023-05-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.